<SEC-DOCUMENT>0001415889-25-006154-index.html : 20250303
<SEC-HEADER>0001415889-25-006154.hdr.sgml : 20250303
<ACCEPTANCE-DATETIME>20250303161817
ACCESSION NUMBER:		0001415889-25-006154
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250228
FILED AS OF DATE:		20250303
DATE AS OF CHANGE:		20250303

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Mitchell Shawnte
		CENTRAL INDEX KEY:			0001749432
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39712
		FILM NUMBER:		25698201

	MAIL ADDRESS:	
		STREET 1:		5959 HORTON STREET
		STREET 2:		SUITE 500
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Olema Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001750284
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				300409740
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		780 BRANNAN STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94103
		BUSINESS PHONE:		(415) 651-3316

	MAIL ADDRESS:	
		STREET 1:		780 BRANNAN STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94103
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-03032025_090314.xml
<TEXT>
Document 1 - file: form4-03032025_090314.html

Document 1 - RAW XML: form4-03032025_090314.xml

</DOCUMENT>
</SEC-DOCUMENT>